• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Hematology changes

















Wouldn’t be surprised as BMS is and always has been a bunch of followers and now that Novartis announced their round of layoffs, Gio and his posse are ready to pull the trigger here

The way the email was carefully peppered with positive language and then "as a next step, these leaders will begin to work on organizing, in some cases, expanding their teams" has me worried.